In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma

Junya Yamaguchi, Alejandra Bergquist, Jianwen Lu, Senthilnath Lakshmanachetty, Safwaan H. Khan, Hideho Okada · 2026

Read In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma by Junya Yamaguchi, Alejandra Bergquist, Jianwen Lu, Senthilnath Lakshmanachetty, Safwaan H. Khan, Hideho Okada (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13297562.txt.

Description

Making CAR-T cells inside the patient's body, instead of in a factory, could widen access to a powerful cancer therapy. Junya Yamaguchi and co-authors review that prospect in 2026, with a focus on the especially hard case of malignant glioma.

Current CAR-T production removes a patient's T cells, engineers them outside the body, and returns them, a slow and costly process. In vivo engineering delivers the receptor blueprint directly, using viral carriers or nanoparticles, and early clinical work in blood cancers looks promising. Glioma adds its own barriers, from drug delivery to the tumor's protected setting. The review weighs those obstacles and the strategies researchers are testing to overcome them.

Catalog record

CREATORJunya Yamaguchi, Alejandra Bergquist, Jianwen Lu, Senthilnath Lakshmanachetty, Safwaan H. Khan, Hideho Okada
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71490
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13297562

Browse the full library · About the Tower of Babel